EONS

EONS is a biotech wellness brand that has just launched Dialed, the first legal psychedelic micro-dose product. By leveraging functional mushrooms and advanced adaptogens, EONS addresses anxiety, sleep, and stress with natural, effective solutions.

Key Highlights:

1. Innovative Product Line:

   • Dialed: The pioneering legal psychedelic micro-dose product.

   • Functional Mushrooms: Natural solutions targeting anxiety, sleep, and stress.

2. Market Position:

   • A unique position in both the legal psychedelic and functional mushroom markets.

   • Protected by key intellectual property (IP) covering the compound and delivery mechanism.

3. Impressive Growth:

   • Achieving 100% year-over-year growth.

   • A robust customer base with over 3,000 active users.

   • 85% gross margins achieved by optimizing production and sales processes.

4. Scientific Backing:

   • Collaborations with leading neuroscientists and research institutions.

   • Products supported by cutting-edge science, utilizing Quicksome™ technology for superior bioavailability.

5. Significant Market Opportunity:

   • Functional Mushroom Market: Valued at $34.4 billion, this rapidly expanding market responds to consumer demand for natural health solutions. Functional mushrooms, known for their adaptogenic and nootropic benefits, are increasingly used for stress management, sleep improvement, and overall wellness.

   • Psychedelic Therapy Market: Estimated at $4.8 billion, this market is poised for substantial growth as legal frameworks evolve, and research supports the therapeutic benefits of psychedelics for mental health issues like depression, anxiety, and PTSD.

Why Invest in EONS?

• Innovative Market Leader: EONS is at the forefront of the emerging legal psychedelic and functional mushroom markets, offering pioneering products with rapid customer growth.

• Proven Traction: With 100% YoY growth, 3,000+ active customers, and 85% gross margins, EONS demonstrates significant market traction and strong customer loyalty.

• Protected Technology: Key IP ensures a competitive edge and market exclusivity.

• Scientific Endorsement: EONS’s products are backed by renowned neuroscientists and research institutions, adding credibility and potential market impact.

• Large Market Potential: Positioned to capture shares in the $34.4 billion functional mushroom market and the $4.8 billion psychedelic therapy market, EONS is well-positioned for substantial growth.